Goldman Sachs Call 170 ABT 20.06..../ DE000GG4SJC6 /
8/30/2024 10:43:12 AM | Chg.+0.001 | Bid5:05:25 PM | Ask5:05:25 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.026EUR | +4.00% | 0.020 Bid Size: 30,000 |
0.030 Ask Size: 30,000 |
Abbott Laboratories | 170.00 USD | 6/20/2025 | Call |
GlobeNewswire
8/6
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
GlobeNewswire
6/6
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
5/9
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
3/25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
3/15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
11/14/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
10/19/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
10/10/2023
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
10/2/2023
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors